LinkedIn Profile

Access IkerChem historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
private:ikerchem 1341367 May 29th, 2019 12:00AM Ikerchem 69 3.00 Open Biotechnology May 28th, 2019 09:57PM May 28th, 2019 09:57PM IkerChem is a leader in the design and development of novel oncology drugs in the epigenetics arena. The company has a strong pipeline of products in development in the principal target areas of DNA Methyltransferase (DNMT) inhibitors with a novel mode of action, next generation potent Histone Deacetylase 6 (HDAC6) inhibitors and the GASC1 target within the JMJ Histone demethylase family. Open Epigenetics, Oncology, DNMT, HDAC, JMJ, Design and Development Open ES IkerChem Pharmaceuticals & Biotechnology
private:ikerchem 1341367 Mar 12th, 2018 12:00AM Ikerchem 61 3.00 Open Biotechnology Mar 12th, 2018 02:47PM Mar 12th, 2018 02:47PM Open IkerChem Pharmaceuticals & Biotechnology
private:ikerchem 1341367 Nov 7th, 2017 12:00AM Ikerchem 59 3.00 Open Biotechnology Nov 7th, 2017 04:28PM Nov 7th, 2017 04:28PM IkerChem is a leader in the design and development of novel oncology drugs in the epigenetics arena. The company has a strong pipeline of products in development in the principal target areas of DNA Methyltransferase (DNMT) inhibitors with a novel mode of action, next generation potent Histone Deacetylase 6 (HDAC6) inhibitors and the GASC1 target within the JMJ Histone demethylase family. IkerChem Pharmaceuticals & Biotechnology
private:ikerchem 1341367 Nov 1st, 2017 12:00AM Ikerchem 59 3.00 Open Biotechnology Nov 1st, 2017 04:14AM Nov 1st, 2017 04:14AM IkerChem is a leader in the design and development of novel oncology drugs in the epigenetics arena. The company has a strong pipeline of products in development in the principal target areas of DNA Methyltransferase (DNMT) inhibitors with a novel mode of action, next generation potent Histone Deacetylase 6 (HDAC6) inhibitors and the GASC1 target within the JMJ Histone demethylase family. IkerChem Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.